Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level

This publication has 37 references indexed in Scilit:

• Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
  The Lancet, 2021
• Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
  Cell, 2021
• Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
  Science, 2021
• SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
  Viruses, 2021
• Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis
  Nature Communications, 2020
• Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2020
• SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
  Nature, 2020
• Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
  Cell, 2020
• Determination of 50% endpoint titer using a simple formula
  World Journal of Virology, 2016
• Investigations of prion and virus safety of a new liquid IVIG product
  Biologicals, 2008